High indoleamine 2,3-dioxygenase transcript levels predict better outcome after front-line cancer immunotherapy

Yu Fujiwara, Shumei Kato, Daisuke Nishizaki, Hirotaka Miyashita, Suzanna Lee, Mary K. Nesline, Jeffrey M. Conroy, Paul DePietro, Sarabjot Pabla, Scott M. Lippman, Razelle Kurzrock

Research output: Contribution to journalArticlepeer-review

3 Scopus citations

Fingerprint

Dive into the research topics of 'High indoleamine 2,3-dioxygenase transcript levels predict better outcome after front-line cancer immunotherapy'. Together they form a unique fingerprint.

Keyphrases

Immunology and Microbiology

Biochemistry, Genetics and Molecular Biology